Webinars

Presented by:

Beverley Zwicker, Tiffany Savary and Meghan Campbell

This year’s webinar will include:  

• Adoption of competency-based scope of practice into the daily practice of all pharmacy professionals in Nova Scotia 
• Professional expectations and lessons learned from professional conduct 
• Reflection on individual competencies through small group case studies

This webinar has been accredited for 1.5 CEUs.

Available until November 1, 2027

See Recoreded Webinars on OpenDal

Presented by Dr. David Gardner

Objectives: 

1. Describe current insomnia guideline recommendations and contrast the role of behavioural and psychological therapies with pharmacological management.
2. Using a stepped care approach, support public and patient access to self-directed and other formats of CBT-I. 
3. Examine overuse of sedatives and interventions to support their safe and effective discontinuation.  

This webinar is accredited for 1 CEU.

Available until October 13, 2027

See Recorded Webinars on OpenDal

Presented by Dr. Tasha Ramsey, Chelsie MacAulay and Mackenzie Hewins

At the end of this session, participants will be able to:

1. Apply principles to effectively have conversations about sexual health.
2. Describe transmission, risk factors, prevention strategies and clinical presentation of chlamydia and gonorrhea.
3. Determine the appropriate anatomical sites and materials to test for chlamydia and gonorrhea.
4. Explain the steps in facilitating chlamydia and gonorrhea self-testing.
5. Assess chlamydia and gonorrhea results, deliver a chlamydia and/or gonorrhea diagnosis, prescribe treatments, and manage follow-up testing.
6. Execute comprehensive counselling following chlamydia and gonorrhea testing and treatment.
7. Summarize the pharmacist’s role in reporting communicable diseases to Public Health and partner notification

This webinar is accredited for 1.5 CEU

See Recorded Webinars on OpenDal

Presented by Lisa Grandy Allen

At the end of this webinar, participants will be able to: 

1. Analyze the evolution of Canadian MAID legislation and ongoing debates
2. Review the ideal pharmacological properties for MAID medications and outline those included in current protocols
3. Detail logistical considerations for MAID prescriptions
4. Provide resources for MAID information and support

This webinar is accredited for 1 CEU.

Available until June 11, 2027

Presented by Dr. Sophie Church

At the end of this webinar, participants will be able to: 

1. Apply evidence-based strategies to manage common clinical scenarios in patients receiving treatment for ADHD. 
2. Identify safety considerations related to ADHD medications in clinical practice, and strategies to mitigate risk of harm. 
3. Differentiate approaches to ADHD management in the presence of comorbid conditions such as anxiety, depression, or substance use disorder.
4. Identify safety considerations related to ADHD medications in clinical practice, and strategies to mitigate risk of harm.

This webinar has been accredited for 1 CEU.

Available until May 7, 2027

Presented by Dr. Sophie Church

At the end of this webinar, participants will be able to:

1. Describe the core symptoms, diagnostic criteria, and epidemiology of ADHD across the lifespan. 
2. Apply current guideline recommendations to optimize ADHD treatment in pharmacy practice. 
3. Compare stimulant and non-stimulant medications for ADHD with respect to mechanisms of action, delivery systems, efficacy, and adverse effects. 
4. Recognize important adverse effects, safety warnings, and monitoring requirements associated with ADHD medications.

This webinar has been accredited for 1 CEU.

Available until April 23, 2027

Presented by Dr. Allison Scott

Grand Rounds presentation on ocular conditions that may require referral to optometry.  We will review which symptoms to listen for to develop a collaborative approach between optometry and pharmacy.

This webinar has been accredited for 1 CEU.

Available until March 31, 2027

Presented by Dr. Cindy Yeung

Each year, 60 in 15,000 newborns at the Neonatal Intensive Care Unit (NICU) in Canada experience adverse drug reactions due to off-label use (the drugs are not approved in neonates). The heavy impact of off-label drugs on neonates is not surprising since 90% of NICU drugs are used off-label in Canada. As another striking statistic, 22,100 mothers (10%) annually in Canada discontinue their drug therapy or breastfeeding due to uncertainty about how their medications might affect their infant. Similar to newborns, there is sparse labelling during lactation. 

Dr. Yeung's expertise in two model types, population PK (popPK) and physiologically based PK (PBPK) modeling, will help predict precise doses for neonates at the NICU and estimate maternal chemical exposures to breastfeeding infants. In this webinar, Dr. Yeung will be discussing how she plans to leverage these two modeling techniques in relation to cardiovascular health, environmental toxicology, and precision dosing.

This webinar has been accredited for 1 CEU.

Available until November 26, 2026

Presented by Dr. Kyle Wilby, Dr. Tasha Ramsey, Mackenzie Hewins and Greg Richard

This session will provide an overview of pre-exposure prophylaxis (PrEP) for HIV and the potential role of a pharmacist as a PrEP prescriber. Presenters will review HIV epidemiology and risk factors, the availability and pharmacological considerations of PrEP, and a prescribing protocol that includes monitoring and assessment of patient eligibility and laboratory values. By the end of the session, participants will be able to follow a protocol for PrEP prescribing as part of a collaborative practice agreement or independent prescribing if approved in Nova Scotia.

This webinar is accredited for 1.5 CEUs

Available until September 22, 2027